Singapore markets open in 1 hour 53 minutes

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.72+0.15 (+1.75%)
At close: 4:00PM EDT
Sign in to post a message.
  • P
    Patrick
    Kara Schultz testify in front of Congress gives CEO chance to shed true light on subject of price fixing. Maybe start of turn around of stock price and future Opioid settlement!πŸ˜€
  • R
    Rui
    The opioid crisis has dominated the public consciousness for several months. We all knew thousands and of lives and communities across the country had been devastated by opioid addition. However, The Guardian crystallized the matter for us: Drug make
    The opioid crisis has dominated the public consciousness for several months. We all knew thousands and of lives and communities across the country had been devastated by opioid addition. However, The Guardian crystallized the matter for us: Drug make
    newyorkshockexchange.com
  • R
    Ronald
    I need some help from the board. I have to raise $430k for a real estate transaction and my 77k shares can certainly do it. Now I am having thoughts of selling some of my gains such as BABA, DOCU, MSFT, etc and holding on to TEVA as I am very hard headed and I know in the long run TEVA is a steal. What do you think?
  • P
    Patrick
    Teva to testify in front of congress next week regarding accusation of price fixing. 😰
  • D
    Danny
    I could not find any news item in the US or in IL that would justify such sell-off. So it is either early reaction to serious event that will be revealed soon, or a play by short sellers. Either way we will find out soon. GLTA.
  • S
    Sunshine
    After the late Rep. Elijah Cummings launched a drug pricing probe of some of the industry's largest players last January, six pharmaceutical execs are set to head to Washington next week for hearings before the panel he chaired, the House Committee o
    After the late Rep. Elijah Cummings launched a drug pricing probe of some of the industry's largest players last January, six pharmaceutical execs are set to head to Washington next week for hearings before the panel he chaired, the House Committee o
    www.fiercepharma.com
  • G
    Golden Dragon
    What's going on? Big volumes trades at the closing bell 453,437 shares @$9.29. Good and bullish sign in my opinion.
  • f
    felix
    first, lots of people on the board are negative which means we should start heading higher soon. second, when the lawyers are done milking everyone then we will have settlement...buy and keep buying because nothing lasts forever....
  • E
    EZDUBL
    Post below was on ENDP board...just showing...not sure of its accuracy

    16.09.2020: Bloomberg Intelligence.
    By Holly Froum.
    Teva and Endo will most likely be able to evade responsibility in a New York State administrative case initiated by Governor Cuomo on opioids. Even if a decision is made against Endo, they will be able to defend the case on appeal. Possible Mutual Billion Dollar Opioid Settlement remain likely.
  • M
    Michael
    Any reason why is has consistently went down from Monday. Per premarket trading included, down nearly 10 peecent
  • H
    Haim
    Teva Have great managment, I bet the company will do well and stock price will rise as well. IT'S hard to be invested in such a stock, but it will be rewarding.
  • M
    Michael
    Last Friday closed 9.48. Start of day today..8.57. Why? Almost 10 percent loss. Why?
  • c
    ca
    Under $12 will be good buy πŸ‘
  • k
    konstantin
    Amazing for a company with 1 billion shares to have an average daily volume of 8 mil. shares. Is this because everyone is waiting?
  • k
    konstantin
    Those that shorted earlier now will start slowly to buy back. Let’s see if they can. Do not sell.
  • M
    Michael
    Obviously there is a disconnect between Teva Mgmt and the investor world . For the third time this year it is headed toward a 25 year low. Kare stated that turnaround plan was completed two quarters ago. Opioid settlement still in play. Damages for fixing scandal is accrued. Yet day after day it is red. Market down big, loses 4 percent, market up big, slightly red closing. Obviously Investor world does not feel confident with Kare. PPS is based on future expectations of company. Kare is not instilling the confidence. It would go a long way of Kare purchased some shares on the open market at these low prices to instill some confidence
  • D
    D.E
    Kare Schultz is a fantastic CEO. I am really impressed by the turnaround he is completing on various difficult fronts such as debt reduction, copaxone sales decrease much lower than expected after patent expiry, quarterly net income and free cash-flow, new product launches, business almost not affected by covid. As soon as a settlement is achieved on the opioid litigation, the pps will skyrocket.